美瑞健康国际产业集团有限公司（股票代码：2327）于2026年1月7日公布翌日披露报表，披露该公司在当日于香港联交所回购1,224,000股普通股股份，回购价介乎每股0.265港元至0.275港元，涉及总金额约330,420港元。
据公告显示，上述股份约占公司已发行股本的0.03%。回购完成后，公司已发行股本维持4,093,756,636股，库藏股数量暂为零。公司曾于2025年6月27日获股东大会通过股份购回授权，授权总额为4,093,756,636股，截至目前合计已回购股份数为32,124,000股，约占授权时已发行股本的0.78%。
公司在公告中确认，此次回购活动符合香港联交所《主板上市规则》和相关法规要求。上述公告由公司秘书蔡贵昆签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.